Janus Living, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
JAN$32.88+2.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Combined and Consolidated Statements of Cash Flows
(In thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $27,874 | $(2,110) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization of real estate and in-place resident contract intangibles | 51,398 | 32,799 |
| Stock-based compensation amortization expense | 34 | — |
| Stock-based compensation issued as part of initial public offering | 4,872 | — |
| Amortization of deferred financing costs and debt discounts (premiums) | (53) | (181) |
| Amortization of non-refundable entrance fees | (27,203) | (24,006) |
| Equity loss (income) from unconsolidated joint venture | (111) | (1,451) |
| Deferred income tax expense (benefit) | 495 | 2,032 |
| Loss (gain) on debt extinguishments | 403 | — |
| Loss (gain) upon change of control, net | (46,270) | — |
| Casualty-related loss (recoveries), net | — | 2,420 |
| Other non-cash items | 112 | — |
| Changes in: | ||
| Decrease (increase) in accounts receivable and other assets, net | (831) | 3,222 |
| Increase (decrease) in accounts payable, accrued liabilities, and other liabilities | (10,400) | (21,084) |
| Increase (decrease) in deferred revenue | 33,001 | 29,176 |
| Net cash provided by (used in) operating activities | 33,321 | 20,817 |
| Cash flows from investing activities: | ||
| Acquisitions of real estate | (402,716) | — |
| Joint venture buyout, net | (291,353) | — |
| Capital expenditures | (20,014) | (15,601) |
| Distributions in excess of earnings from unconsolidated joint venture | — | 4,280 |
| Proceeds from insurance recovery | 6,838 | — |
| Net cash provided by (used in) investing activities | (707,245) | (11,321) |
| Cash flows from financing activities: | ||
| Issuance of Class A-1 common stock in connection with initial public offering, net of underwriting fees | 901,326 | — |
| Issuance of Class A-2 common stock in connection with initial public offering | 759 | — |
| Repayments of mortgage debt | (102,011) | (710) |
| Payments for debt extinguishment and deferred financing costs | (2,745) | — |
| Payments of offering costs | (6,256) | — |
| Net contributions from (distributions to) Parent | 836,737 | (3,221) |
| Distributions to and purchase of noncontrolling interests | (354) | — |
| Net cash provided by (used in) financing activities | 1,627,456 | (3,931) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 953,532 | 5,565 |
| Cash, cash equivalents, and restricted cash, beginning of period | 84,261 | 79,066 |
| Cash, cash equivalents, and restricted cash, end of period | $1,037,793 | $84,631 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.